NCT01446822
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
- Locations
-
- Cantonal Hospital of St.Gallen Sankt Gallen, Switzerland
Clinical trial condition
Urologic Neoplasms
Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.
2,952 public trials
630 recruiting studies
Urologic Neoplasms trial results
NCT00448721
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Investigative Site Duarte, California, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Investigative Site Philadelphia, Pennsylvania, United States
- Investigative Site Nashville, Tennessee, United States
NCT02328417
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Hospital Universitario Principe de Asturias Alcalá de Henares, Madrid, Spain
- Hospital Universitario Fundación Alcorcón Alcorcón, Madrid, Spain
- Hospital Universitario de Getafe Getafe, Madrid, Spain
- Hospital Universitario Severo Ochoa Leganés, Madrid, Spain
NCT02075658
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- University of California, Irvine Medical Center Orange, California, United States
NCT01982097
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Multiple Locations, Russia
NCT01090466
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
NCT00498966
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Cancer, +9 more
- Locations
-
- Investigative Site Louisville, Kentucky, United States
- Investigative Site Morristown, New Jersey, United States
- Investigative Site Armonk, New York, United States
Completed
A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers
NCT01460134
- Conditions
- Adenocarcinoma, Adnexal Diseases, Any T-cell Malignancy, +70 more
- Locations
-
- Mayo Clinic Arizona - Cancer Clinical Research Unit Scottsdale, Arizona, United States
- Stanford Cancer Center - Stanford University Stanford, California, United States
- Mayo Clinic Rochester, Minnesota, United States
- Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine New York, United States
NCT02295982
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +9 more
- Locations
-
- Roskilde Hospital Roskilde, Denmark
NCT01215071
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- University of Cologne Cologne, Germany
- Hospital Holweide Cologne, Germany
- Urological hospital, Städt. Kliniken Dortmund Dortmund, Germany
- Paracelsus Hospital Düsseldorf, Germany